Marco Dotto is an experienced professional in the biotechnology and venture capital sectors, currently serving as Chief Operating Officer and Director of the board at Rubedo Life Sciences, a company focused on innovative therapies targeting senescent cells related to chronic age-related diseases. Dotto is also a co-founder and CEO of Biodiversa s.r.l., which offers Next Generation Sequencing services and bioinformatics solutions. In addition to roles as Limited Partner at multiple venture capital firms including Unruly Capital and Eden Venture, Dotto invests in disruptive technologies and angel funds, including SiZable Energy and Nurture Genomics, aimed at advancing energy solutions and genomic insights for pediatric care, respectively. Dotto holds an extensive educational background in biotechnology and management from institutions such as UC San Diego and Università degli Studi di Padova.
This person is not in any teams
This person is not in any offices